Applied Therapeutics Inc [APLT] stock prices are down -12.18% to $0.22 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The APLT shares have gain 4.17% over the last week, with a monthly amount drifted -73.81%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Applied Therapeutics Inc [NASDAQ: APLT] stock has seen the most recent analyst activity on December 03, 2025, when Leerink Partners downgraded its rating to a Market Perform but kept the price target unchanged to $1 for it. Previously, William Blair downgraded its rating to Mkt Perform on December 23, 2024. On December 02, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $2 on the stock. RBC Capital Mkts downgraded its rating to a Sector Perform and decreased its price target to $4 on November 29, 2024. William Blair initiated its recommendation with an Outperform. RBC Capital Mkts started tracking with an Outperform rating for this stock on March 26, 2024, and assigned it a price target of $12. In a note dated February 22, 2024, Leerink Partners initiated an Outperform rating and provided a target price of $12 on this stock.
The stock price of Applied Therapeutics Inc [APLT] has been fluctuating between $0.20 and $1.50 over the past year. Currently, Wall Street analysts expect the stock to reach $4.5 within the next 12 months. Applied Therapeutics Inc [NASDAQ: APLT] shares were valued at $0.22 at the most recent close of the market. An investor can expect a potential return of 1945.45% based on the average APLT price forecast.
Analyzing the APLT fundamentals
The Applied Therapeutics Inc [NASDAQ:APLT] reported sales of 1.00M for trailing twelve months, representing a surge of 719.67%. Gross Profit Margin for this corporation currently stands at -0.29% with Operating Profit Margin at -98.4%, Pretax Profit Margin comes in at -18.14%, and Net Profit Margin reading is -18.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.66 and Total Capital is -66.85. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-4.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2067 points at the first support level, and at 0.1933 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2448, and for the 2nd resistance point, it is at 0.2695.
Ratios To Look Out For
It’s worth pointing out that Applied Therapeutics Inc [NASDAQ:APLT]’s Current Ratio is 0.96. In addition, the Quick Ratio stands at 0.96 and the Cash Ratio stands at 0.36. Considering the valuation of this stock, the price to sales ratio is 31.75.
Transactions by insiders
Recent insider trading involved Perfetti Riccardo, Chief Medical Officer, that happened on Mar 04 ’25 when 10366.0 shares were sold. Funtleyder Leslie D. completed a deal on Mar 04 ’25 to sell 14502.0 shares. Meanwhile, Chinoporos Constantine sold 447.0 shares on Mar 04 ’25.
